Table 2.
Haematological parameters of B. melitensis-infected BALB/c mice treated with C. mongolica root extract, antibiotic or the combination of both
| Treatment group | Content of Blood cells (in μl) | ||||
|---|---|---|---|---|---|
| WBC (×103) | LYM (%) | OTHR (%) | EO (%) | Neutrophil phagacytosis activity (%) | |
| Non infected | 3.05 ± 0.2 | 73.4 ± 8.5 | 22.2 ± 4 | 1.4 ± 0.28 | 13 ± 2.8 |
| Pretreatment | 6.4 ± 0.7 | 59.7 ± 4.2 | 38.03 ± 5.6 | 3.6 ± 0.75 | 49 ± 6.5 |
| Non treatment | 5.7 ± 0.1 | 63.8 ± 9.02 | 34.9 ± 8.9 | 1.26 ± 0.7 | 38 ± 2 |
| Doxycycline | 4.7 ± 0.01* | 60.05 ± 0.3 | 37.5 ± 0.3 | 2.4 ± 0.1 | 14.5 ± 3.5* |
| Combination treatment | 4.3 ± 0.5* | 61.8 ± 8.4 | 32.7 ± 5.5 | 1.93 ± 0.4 | 18.5 ± 3.5* |
| C.mongolica root extract | 4.2 ± 0.9* | 63.4 ± 3.6 | 34.4 ± 3.3 | 2.1 ± 0.9 | 21 ± 2.5* |
Statistical analysis: *P < 0.05 compared to the non-treatment group